2025 annual financial data
Biodexa Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -8,268,734 GBP and net income was -6,244,097 GBP.
Operating cash flow was -5,394,140 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -8,268,734 GBP
- Net income
- -6,244,097 GBP
- Operating cash flow
- -5,394,140 GBP